LXU Fundamental Analysis - LSB INDUSTRIES INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to LXU. LXU was compared to 85 industry peers in the Chemicals industry. While LXU seems to be doing ok healthwise, there are quite some concerns on its profitability. LXU does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LXU was profitable.

In the past year LXU had a positive cash flow from operations.

In multiple years LXU reported negative net income over the last 5 years.

LXU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.26%, LXU is doing worse than 68.24% of the companies in the same industry.

Looking at the Return On Equity, with a value of -5.43%, LXU is doing worse than 65.88% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROIC	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of LXU has declined.

With a Gross Margin value of 7.56%, LXU is not doing good in the industry: 85.88% of the companies in the same industry are doing better.

LXU's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for LXU so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.56%

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, LXU has less shares outstanding

LXU has more shares outstanding than it did 5 years ago.

The debt/assets ratio for LXU has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.42, we must say that LXU is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 1.42, LXU is not doing good in the industry: 70.59% of the companies in the same industry are doing better.

LXU has a Debt/Equity ratio of 0.99. This is a neutral value indicating LXU is somewhat dependend on debt financing.

The Debt to Equity ratio of LXU (0.99) is worse than 67.06% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Altman-Z	1.42

ROIC/WACCN/A

WACC9.16%

2.3 Liquidity

A Current Ratio of 2.51 indicates that LXU has no problem at all paying its short term obligations.

With a decent Current ratio value of 2.51, LXU is doing good in the industry, outperforming 70.59% of the companies in the same industry.

LXU has a Quick Ratio of 2.29. This indicates that LXU is financially healthy and has no problem in meeting its short term obligations.

LXU has a better Quick ratio (2.29) than 83.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.51
Quick Ratio	2.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.67% over the past year.

Looking at the last year, LXU shows a decrease in Revenue. The Revenue has decreased by -4.23% in the last year.

The Revenue has been growing slightly by 7.43% on average over the past years.

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

3.2 Future

LXU is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.

The Revenue is expected to grow by 3.20% on average over the next years.

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.53, LXU is valued on the expensive side.

Compared to the rest of the industry, the Price/Earnings ratio of LXU is on the same level as its industry peers.

LXU's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.91.

With a Price/Forward Earnings ratio of 82.13, LXU can be considered very expensive at the moment.

Based on the Price/Forward Earnings ratio, LXU is valued a bit more expensive than the industry average as 70.59% of the companies are valued more cheaply.

The average S&P500 Price/Forward Earnings ratio is at 37.11. LXU is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	18.53
Fwd PE	82.13

4.2 Price Multiples

LXU's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	10.56

4.3 Compensation for Growth

A cheap valuation may be justified as LXU's earnings are expected to decrease with -8.48% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

LXU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LSB INDUSTRIES INC

NYSE:LXU (7/29/2025, 7:57:46 PM)

After market: 8.5 -0.21 (-2.41%)

8.71

+0.07 (+0.81%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)04-29 2025-04-29/amc

Earnings (Next)07-29 2025-07-29/amc

Inst Owners54.39%

Inst Owner Change-0.08%

Ins Owners4.22%

Ins Owner Change0.29%

Market Cap626.07M

Analysts77.5

Price Target8.39 (-3.67%)

Short Float %3.99%

Short Ratio4.69

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)102.45%

Min EPS beat(2)69.76%

Max EPS beat(2)135.15%

EPS beat(4)4

Avg EPS beat(4)103.34%

Min EPS beat(4)69.76%

Max EPS beat(4)135.15%

EPS beat(8)6

Avg EPS beat(8)43.21%

EPS beat(12)8

Avg EPS beat(12)22.5%

EPS beat(16)10

Avg EPS beat(16)37.33%

Revenue beat(2)2

Avg Revenue beat(2)9.9%

Min Revenue beat(2)6.25%

Max Revenue beat(2)13.55%

Revenue beat(4)3

Avg Revenue beat(4)6.5%

Min Revenue beat(4)-6.62%

Max Revenue beat(4)13.55%

Revenue beat(8)7

Avg Revenue beat(8)5.28%

Revenue beat(12)10

Avg Revenue beat(12)4.96%

Revenue beat(16)11

Avg Revenue beat(16)3.09%

PT rev (1m)0%

PT rev (3m)-6.53%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-4.81%

EPS NY rev (1m)0%

EPS NY rev (3m)3.13%

Revenue NQ rev (1m)2.29%

Revenue NQ rev (3m)3.13%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.34%

Valuation

		Industry Rank	Sector Rank
PE	18.53
Fwd PE	82.13
P/S	1.19
P/FCF	N/A
P/OCF	9.03
P/B	1.28
P/tB	1.28
EV/EBITDA	10.56

EPS(TTM)0.47

EY5.4%

EPS(NY)0.11

Fwd EY1.22%

FCF(TTM)-0.36

FCFYN/A

OCF(TTM)0.96

OCFY11.07%

SpS7.34

BVpS6.82

TBVpS6.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.56%
FCFM	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)9.64%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

F-Score4

Asset Turnover0.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Debt/EBITDA	6.46
Cap/Depr	122.77%
Cap/Sales	17.98%
Interest Coverage	N/A
Cash Conversion	92.06%
Profit Quality	N/A
Current Ratio	2.51
Quick Ratio	2.29
Altman-Z	1.42

F-Score4

WACC9.16%

ROIC/WACCN/A

Cap/Depr(3y)96.58%

Cap/Depr(5y)76.59%

Cap/Sales(3y)11.38%

Cap/Sales(5y)9.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

EBIT growth 1Y-106.18%

EBIT growth 3Y-60.57%

EBIT growth 5YN/A

EBIT Next Year2094.57%

EBIT Next 3Y191.05%

EBIT Next 5Y92.67%

FCF growth 1Y-109.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-78.3%

OCF growth 3Y-0.4%

OCF growth 5Y110.4%

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens